Publication | Closed Access

Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model

Liraglutide AmelioratesNeurodegenerative DiseasesAlzheimer's DiseaseAmyloid β ProteinMedicineDegenerative DiseaseDegenerative PathologyProtein MisfoldingNeuroscienceCell BiologyNeurodegenerationPharmacologySynaptic SignalingSubcutaneous AdministrationProtective Mechanisms